These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24844843)

  • 1. Mass spectrometry in clinical chemistry: the case of newborn screening.
    la Marca G
    J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
    Ozben T
    Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.
    Lim JS; Tan ES; John CM; Poh S; Yeo SJ; Ang JS; Adakalaisamy P; Rozalli RA; Hart C; Tan ET; Ranieri E; Rajadurai VS; Cleary MA; Goh DL
    Mol Genet Metab; 2014; 113(1-2):53-61. PubMed ID: 25102806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying targeted next generation sequencing to dried blood spot specimens from suspicious cases identified by tandem mass spectrometry-based newborn screening.
    Qian J; Wang X; Liu J; Zhong J; Le Y; Melchior Tellier LCA; Liu C; Jiang P; Gao R; Wang Y
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):979-988. PubMed ID: 28771436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a second-tier test panel in dried blood spot samples using liquid chromatography-tandem mass spectrometry in Catalonia's newborn screening programme.
    Pajares-García S; González de Aledo-Castillo JM; Flores-Jiménez JE; Collado T; Pérez J; Paredes-Fuentes AJ; Argudo-Ramírez A; López-Galera RM; Prats B; García-Villoria J
    Clin Chem Lab Med; 2024 Feb; 62(3):493-505. PubMed ID: 37794778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for disease in the newborn: the evidence base for blood-spot screening.
    Wilcken B
    Pathology; 2012 Feb; 44(2):73-9. PubMed ID: 22198252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
    Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tandem mass spectrometry as screening for inborn errors of metabolism].
    Campos H D
    Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry.
    Tortorelli S; Turgeon CT; Lim JS; Baumgart S; Day-Salvatore DL; Abdenur J; Bernstein JA; Lorey F; Lichter-Konecki U; Oglesbee D; Raymond K; Matern D; Schimmenti L; Rinaldo P; Gavrilov DK
    J Pediatr; 2010 Aug; 157(2):271-5. PubMed ID: 20394947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining First and Second-Tier Newborn Screening in a Single Assay Using High-Throughput Chip-Based Capillary Electrophoresis Coupled to High-Resolution Mass Spectrometry.
    Austin Pickens C; Isenberg SL; Cuthbert C; Petritis K
    Clin Chem; 2021 Nov; 67(12):1709-1720. PubMed ID: 34606607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.